image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

4Imprint - 20% increase in sales in first four months

June 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FOUR
  • Price:
  • 1090p
The shares hit a new high of 1160p after US promotional products firm 4imprint unveiled a 20.7% increase in revenues for the first four months of the year. Order intake rose almost 22% with a good balance between order levels from new and existing customers.Peel Hunt has left forecasts unchanged for now (2015 eps: 80.1 cents) but expects to make upgrades later in the year.It just gets better and better for 4imprint but with only 4% of the market, it still has bags of growth potential. Tipped at 276p in April ‘12, the shares have now gained 295%. Hold on for more.  ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X